|
PDZD8 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.65159999999664E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.406360E-04 |
| Normal-vs-Stage2 |
6.664400E-03 |
| Normal-vs-Stage3 |
2.36099999995076E-06 |
| Normal-vs-Stage4 |
1.553110E-04 |
| Stage1-vs-Stage2 |
7.120200E-01 |
| Stage1-vs-Stage3 |
1.611960E-01 |
| Stage1-vs-Stage4 |
4.716400E-01 |
| Stage2-vs-Stage3 |
1.835160E-01 |
| Stage2-vs-Stage4 |
3.646800E-01 |
| Stage3-vs-Stage4 |
7.389600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.89476999999938E-05 |
| Normal-vs-AfricanAmerican |
1.964140E-02 |
| Normal-vs-Asian |
4.20450000000461E-05 |
| Caucasian-vs-AfricanAmerican |
6.380200E-01 |
| Caucasian-vs-Asian |
4.127400E-01 |
| AfricanAmerican-vs-Asian |
3.010200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.50700000034476E-07 |
| Normal-vs-Female |
1.551220E-04 |
| Male-vs-Female |
3.237700E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.188900E-04 |
| Normal-vs-Age(41-60Yrs) |
1.22359999998878E-06 |
| Normal-vs-Age(61-80Yrs) |
2.957800E-04 |
| Normal-vs-Age(81-100Yrs) |
1.593950E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.408230E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.815200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.298000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.910000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.081200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.566000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.043400E-01 |
| Classical-VS-Follicular |
3.573800E-01 |
| Classical-VS-Other |
6.986500E-02 |
| Classical-VS-Normal |
1.996490E-04 |
| Tall-VS-Follicular |
5.698200E-01 |
| Tall-VS-Other |
1.958430E-01 |
| Tall-VS-Normal |
2.393100E-04 |
| Follicular-VS-Other |
1.765430E-01 |
| Follicular-VS-Normal |
3.234900E-04 |
| Other-VS-Normal |
1.364350E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.7813299999947E-05 |
| Normal-vs-N1 |
2.38099999999575E-05 |
| N0-vs-N1 |
3.228800E-01 |
|
|
